Business Context and Reporting Period
NanoViricides, Inc. (NNVC), a Nevada corporation, filed this Form 8-K on September 22, 2019, reporting a corporate action effective September 24, 2019. The company is listed on the NYSE American.
Key Financial Metrics
This filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a capital structure amendment.
Material Changes
The company executed a 1-for-20 reverse stock split of its Common Stock and Preferred Stock. Consequently, the authorized capital stock was reduced to 7,500,000 shares of Common Stock and 500,000 shares of Preferred Stock. Post-split, approximately 3,844,921 shares of Common Stock and 255,714 shares of Preferred Stock are outstanding.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the procedural details of the stock split.
Investor Verification Checklist
- Verify the effective date of the 1-for-20 reverse stock split (September 24, 2019).
- Confirm the new authorized share counts: 7,500,000 Common and 500,000 Preferred.
- Review the adjusted outstanding share counts: ~3,844,921 Common and ~255,714 Preferred.
- Check the Certificate of Change (Exhibit 3.1) for legal finalization of the Articles of Incorporation amendment.